Fractionation of bioactive materials temulawak rhizome (Curcuma xanthorrhiza) on fungal Candida albicans in search of phytopharmaca
Abstract
Candida albicans fungus is a microbiota in the human body that is opportunistic. In general, infections caused by C. albicans are called candidiasis. Some studies have shown that C. albicans is resistant to antifungal agents, so an alternative antifungal medication is needed at affordable and safe prices. One alternative is to increase the use of medicinal herbs. The purpose of the research was to study the possibility of utilizing the Temulawak rhizome as a phytopharmaca material to treat candidiasis disease by C. albicans infection. The specific objective is to isolate the bioactive material and to determine the class of antifungal active fraction of Temulawak rhizome against C. albicans. Isolation of temulawak rhizome by way of extracted by stratified using soxhlet, then done fractionation using the method of vacuum chromatography, then bioautographic test using thin plate chromatography. Testing of bioactive fraction temulawak rhizome using thin plate chromatography obtained purple color indicating the class of terpenoids compounds and yellow color indicating the class of phenols compounds. The fraction of methanol extract from Temulawak rhizome makes it possible to be used as raw material of phytopharmaca because it has antifungal effectiveness against C. albicans.
- Publication:
-
Journal of Physics Conference Series
- Pub Date:
- November 2019
- DOI:
- 10.1088/1742-6596/1375/1/012015
- Bibcode:
- 2019JPhCS1375a2015N